Accueil>Recherche>Essais cliniques>LCA

How to use the speech recognition tool?

NCT00481546

LCA

Phase I Trial of Gene Vector to Patients with Retinal Disease due to
RPE65 mutations

Type: Interventional



Status of the trial: Active, Not recruiting

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2007-07-01
  • Closing Date: 2026-06-01

Criteria

More information

Children: Yes

Adults: Yes

Funder Type: other

HCP: Principal investigators

HCP: Other investigators

Within ERN-EYE members

Principal investigators



Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe

* indicates required

This ERN is supported by: